His primary areas of investigation include Virology, Immunology, Antigen, Cytotoxic T cell and Antigen presentation. His study in Virology is interdisciplinary in nature, drawing from both Effector, CD8, Immune system and Mycobacterium tuberculosis. Many of his studies on Immunology involve topics that are commonly interrelated, such as Endothelial stem cell.
His work on Cytotoxic T cell is being expanded to include thematically relevant topics such as Microbiology. His Antigen presentation study combines topics from a wide range of disciplines, such as Molecular biology and CD1. The study incorporates disciplines such as Natural killer T cell and CD40 in addition to Antigen-presenting cell.
David M. Lewinsohn mostly deals with Immunology, Mycobacterium tuberculosis, Antigen, Virology and Cytotoxic T cell. David M. Lewinsohn has included themes like Mycobacterium, Microbiology and Vaccination in his Mycobacterium tuberculosis study. His Antigen research includes themes of T cell, Antigen presentation, T-cell receptor and Clone.
In his study, which falls under the umbrella issue of Antigen presentation, Cell activation is strongly linked to Cell biology. David M. Lewinsohn combines subjects such as Epitope, Human leukocyte antigen and Tuberculosis vaccines with his study of Virology. Cytotoxic T cell and CD8 are commonly linked in his work.
The scientist’s investigation covers issues in Mycobacterium tuberculosis, Antigen, Immune system, Tuberculosis and Immunology. His work deals with themes such as Microbiology and Vaccination, which intersect with Mycobacterium tuberculosis. The various areas that David M. Lewinsohn examines in his Antigen study include T cell, Antigen presentation, Cell and Cell biology.
His Tuberculosis research integrates issues from Acquired immune system, Internal medicine, Disease and Intensive care medicine. His studies in Immunology integrate themes in fields like Cluster of differentiation and Mycobacterium. His CD8 research is multidisciplinary, incorporating perspectives in Molecular biology and Cytotoxic T cell.
His primary areas of study are Mycobacterium tuberculosis, Tuberculosis, Immune system, Immunology and Disease. His Mycobacterium tuberculosis study combines topics in areas such as Airborne disease and Microbiology. His Immune system study integrates concerns from other disciplines, such as Tumor necrosis factor alpha, Metabolome and Antigen.
David M. Lewinsohn integrates many fields in his works, including Immunology and Lipoteichoic acid. His CD8 research is multidisciplinary, relying on both Cytotoxic T cell and Vaccination. David M. Lewinsohn has researched Major histocompatibility complex in several fields, including Computational biology and Antigen presentation.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Individual RD1-region genes are required for export of ESAT-6/CFP-10 and for virulence of Mycobacterium tuberculosis
Kristi M. Guinn;Mark J. Hickey;Sanjeev K. Mathur;Kelly L. Zakel.
Molecular Microbiology (2004)
Human Mucosal Associated Invariant T Cells Detect Bacterially Infected Cells
Marielle C. Gold;Marielle C. Gold;Stefania Cerri;Susan Smyk-Pearson;Meghan E. Cansler.
PLOS Biology (2010)
Leukocyte-endothelial cell recognition: evidence of a common molecular mechanism shared by neutrophils, lymphocytes, and other leukocytes.
D M Lewinsohn;R F Bargatze;E C Butcher.
Journal of Immunology (1987)
Vitamin D is required for IFN-gamma-mediated antimicrobial activity of human macrophages.
Mario Fabri;Steffen Stenger;Dong Min Shin;Jae Min Yuk.
Science Translational Medicine (2011)
Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention Clinical Practice Guidelines: Diagnosis of Tuberculosis in Adults and Children
David M. Lewinsohn;Michael K. Leonard;Philip A. LoBue;David L. Cohn.
Clinical Infectious Diseases (2017)
Cytomegalovirus US2 destroys two components of the MHC class II pathway, preventing recognition by CD4+ T cells
Roman Tomazin;Jessica Boname;Jessica Boname;Nagendra R. Hegde;David M. Lewinsohn.
Nature Medicine (1999)
Frequencies of HCV‐specific effector CD4+ T cells by flow cytometry: Correlation with clinical disease stages
Hugo R. Rosen;Camette Miner;Anna W. Sasaki;David M. Lewinsohn.
Hepatology (2002)
HLA-E-dependent presentation of Mtb-derived antigen to human CD8+ T cells.
Amy S. Heinzel;Jeff E. Grotzke;Jeff E. Grotzke;Rebecca A. Lines;Deborah A. Lewinsohn.
Journal of Experimental Medicine (2002)
CHARACTERIZATION OF HUMAN CD8+ T CELLS REACTIVE WITH MYCOBACTERIUM TUBERCULOSIS-INFECTED ANTIGEN-PRESENTING CELLS
David M. Lewinsohn;David M. Lewinsohn;Mark R. Alderson;Andria L. Briden;Stanley R. Riddell.
Journal of Experimental Medicine (1998)
Immune evasion versus recovery after acute hepatitis C virus infection from a shared source
Ian Tester;Ian Tester;Susan Smyk-Pearson;Susan Smyk-Pearson;Ping Wang;Anne Wertheimer.
Journal of Experimental Medicine (2005)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Stanford University
Program for Appropriate Technology in Health
University of Southern California
University of Oklahoma Health Sciences Center
University of Cape Town
MIT
Monash University
Infectious Disease Research Institute
Case Western Reserve University
University College London
Vienna University of Economics and Business
Openstream, Inc.
University of Colorado Boulder
Carnegie Mellon University
Keio University
Federal University of Toulouse Midi-Pyrénées
University of York
NEIKER, the Basque Institute for Agricultural Research and Development
Sewanee: The University of the South
University of Cambridge
Torrey Pines Institute For Molecular Studies
University of Orléans
Columbia University
Duke University
Spanish National Research Council
Boston Children's Hospital